腹膜播種にて結腸閉塞を来した切除不能肝門部胆管癌の1例
Saved in:
| Published in | Journal of UOEH Vol. 44; no. 3; pp. 277 - 286 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
学校法人 産業医科大学
01.09.2022
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0387-821X 2187-2864 |
| DOI | 10.7888/juoeh.44.277 |
Cover
| Author | 豊福, 篤志 伊藤, 一馬 日暮, 愛一郎 崎田, 健一 櫻井, 晶子 四元, 真司 吉田, 昴平 永田, 直幹 山口, 晋作 黒田, 宏昭 |
|---|---|
| Author_xml | – sequence: 1 fullname: 黒田, 宏昭 organization: 北九州総合病院 救急科 – sequence: 1 fullname: 伊藤, 一馬 organization: 北九州総合病院 外科 – sequence: 1 fullname: 吉田, 昴平 organization: 北九州総合病院 外科 – sequence: 1 fullname: 山口, 晋作 organization: 北九州総合病院 放射線科 – sequence: 1 fullname: 崎田, 健一 organization: 北九州総合病院 病理診断科 – sequence: 1 fullname: 日暮, 愛一郎 organization: 北九州総合病院 外科 – sequence: 1 fullname: 四元, 真司 organization: 北九州総合病院 放射線科 – sequence: 1 fullname: 櫻井, 晶子 organization: 北九州総合病院 外科 – sequence: 1 fullname: 永田, 直幹 organization: 北九州総合病院 外科 – sequence: 1 fullname: 豊福, 篤志 organization: 北九州総合病院 外科 |
| BookMark | eNo9UE1LAkEAHcIgtW79jbWZ2dmZ2VOE9AWCl4Juy7g7potp7NqhW6uoRQXhwRCyECqEaG-BHerPrLq7_yL7oMt7Dx7vwXspkKjWqhKAVQQzjHO-Zp_UZClDSAYztgCSGHGmYE5JAiShOtcco4MlkHJdG0KNE6QlQT5qvUftu1n3NRz5gfcSeM_h203UGse9i-nwPmh0Z4OnwLsNvIfpeSfuP07G11HzI2oM4t5Z3BxFzXboD8P-VeD5aPJ5uQwWi6LiypU_ToP9rc297I6Sy2_vZjdyio0wFkpBJ6pu6lIKkwjKsEkZR7yILUoKiEjIkCosTriGJYUQzffAArUk1C2i6UxSNQ3Wf3ttty4OpXHslI-Ec2oIp142K9L4ucIgxFC_YZ7_d8yScAxbqF-7CnaC |
| ContentType | Journal Article |
| Copyright | 2022 産業医科大学 |
| Copyright_xml | – notice: 2022 産業医科大学 |
| DOI | 10.7888/juoeh.44.277 |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2187-2864 |
| EndPage | 286 |
| ExternalDocumentID | article_juoeh_44_3_44_277_article_char_ja |
| GroupedDBID | --- 5GY ALMA_UNASSIGNED_HOLDINGS F5P JMI JSF JSH KQ8 MOJWN RJT RZJ |
| ID | FETCH-LOGICAL-j122a-b9439c9eeac4a672c67818f2d64b14e0713ad84852e60012770b6de09d4597e63 |
| ISSN | 0387-821X |
| IngestDate | Wed Sep 03 06:31:01 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j122a-b9439c9eeac4a672c67818f2d64b14e0713ad84852e60012770b6de09d4597e63 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/juoeh/44/3/44_277/_article/-char/ja |
| PageCount | 10 |
| ParticipantIDs | jstage_primary_article_juoeh_44_3_44_277_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2022/09/01 |
| PublicationDateYYYYMMDD | 2022-09-01 |
| PublicationDate_xml | – month: 09 year: 2022 text: 2022/09/01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | Journal of UOEH |
| PublicationTitleAlternate | 産業医大誌 |
| PublicationYear | 2022 |
| Publisher | 学校法人 産業医科大学 |
| Publisher_xml | – name: 学校法人 産業医科大学 |
| References | 17 . Autorino R, Mattiucci GC, Ardito F et al (2016): Radiochemotherapy with gemcitabine in unresectable extrahepatic cholangiocarcinoma: Long-term results of a phase II study. Anticancer Res 36 (2): 737−740 2 . Matsuda T, Ajiki W, Marugame T et al (2010): Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: A chronological and international comparative study. Japanese Journal of Clinical Oncology 41 (1): 40−51 (in Japanese) 5 . Peixoto RD, Renouf D & Lim H (2014): A population based analysis of prognostic factors in advanced biliary tract cancer. J Gastrointest Oncol 5 (6): 428−432 11 . Morizane C, Okusaka T, Mizusawa J et al (2019): Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial. Ann Oncol 30 (12): 1950−1958 20 . Nakamura H, Arai Y, Totoki Y et al (2015): Genomic spectra of biliary tract cancer. Nat Genet 47 (9): 1003−1010 8 . Válek V, Kysela P, Kala Z, Kiss I, Tomášek J & Petera J (2007): Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: A prospective randomised study. European Journal of Radiology 62 (2): 175−179 4 . Valle J, Wasan H, Palmer DH et al (2010): Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362 (14): 1273−1281 12 . Sakai D, Kanai M, Kobayashi S et al (2018): Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA). Annals of Oncology 29: viii205 10 . Valle J, Wasan H, Palmer DH et al (2010): Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362 (14): 1273−1281 15 . Lin LL, Picus J, Drebin JA et al (2005): A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. Am J Clin Oncol 28 (3): 234−241 7 . Shinohara ET, Mitra N, Guo M & Metz JM (2009): Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. Int J Radiat Oncol Biol Phys 74 (4): 1191−1198 14 . Foo ML, Gunderson LL, Bender CE & Buskirk SJ (1997): External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J of Radiat Oncol Biol Phys 39 (4): 929−935 21 . Wardell CP, Fujita M, Yamada T et al (2018): Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol 68 (5): 959−969 13 . National Comprehensive Cancer Network (2021): NCCN Clinical Practice Guidelines in Oncology. Hepatobiliary Cancers (version 5). https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf (accessed February 4, 2022) 6 . Shinchi H, Takao S, Nishida H & Aikou T (2000): Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol 75 (2): 89−94 19 . Mano H (2020): Cancer genomic medicine in Japan. Proc Jpn Acad Ser B Phy Biol Sci 96 (7): 316−320 9 . Nagino M, Hirano S, Yoshitomi H et al (2021): Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci 28 (1): 26−54 16 . Park JY, Park SW, Chung JB et al (2006): Concurrent chemoradiotherapy with doxifluridine and paclitaxel for extrahepatic bile duct cancer. Am J Clin Oncol 29 (3): 240−245 18 . Lee KJ, Yi SW, Cha J et al (2016): A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer. Cancer Chemother Pharmacol 78 (4): 841−846 1 . National Cancer Center, Japan : Cancer Statistics. Cancer Information Service.https://ganjoho.jp/reg_stat/statistics/data/dl/index.html#a14(accessed January 10, 2022) (in Japanese) 3 . Patel T (2011): Cholangiocarcinoma-controversies and challenges. Nat Rev Gastroenterol & Hepatol 8 (4): 189−200 |
| References_xml | – reference: 4 . Valle J, Wasan H, Palmer DH et al (2010): Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362 (14): 1273−1281 – reference: 2 . Matsuda T, Ajiki W, Marugame T et al (2010): Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: A chronological and international comparative study. Japanese Journal of Clinical Oncology 41 (1): 40−51 (in Japanese) – reference: 21 . Wardell CP, Fujita M, Yamada T et al (2018): Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol 68 (5): 959−969 – reference: 3 . Patel T (2011): Cholangiocarcinoma-controversies and challenges. Nat Rev Gastroenterol & Hepatol 8 (4): 189−200 – reference: 6 . Shinchi H, Takao S, Nishida H & Aikou T (2000): Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol 75 (2): 89−94 – reference: 11 . Morizane C, Okusaka T, Mizusawa J et al (2019): Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial. Ann Oncol 30 (12): 1950−1958 – reference: 5 . Peixoto RD, Renouf D & Lim H (2014): A population based analysis of prognostic factors in advanced biliary tract cancer. J Gastrointest Oncol 5 (6): 428−432 – reference: 17 . Autorino R, Mattiucci GC, Ardito F et al (2016): Radiochemotherapy with gemcitabine in unresectable extrahepatic cholangiocarcinoma: Long-term results of a phase II study. Anticancer Res 36 (2): 737−740 – reference: 9 . Nagino M, Hirano S, Yoshitomi H et al (2021): Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci 28 (1): 26−54 – reference: 7 . Shinohara ET, Mitra N, Guo M & Metz JM (2009): Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. Int J Radiat Oncol Biol Phys 74 (4): 1191−1198 – reference: 16 . Park JY, Park SW, Chung JB et al (2006): Concurrent chemoradiotherapy with doxifluridine and paclitaxel for extrahepatic bile duct cancer. Am J Clin Oncol 29 (3): 240−245 – reference: 12 . Sakai D, Kanai M, Kobayashi S et al (2018): Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA). Annals of Oncology 29: viii205 – reference: 10 . Valle J, Wasan H, Palmer DH et al (2010): Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362 (14): 1273−1281 – reference: 14 . Foo ML, Gunderson LL, Bender CE & Buskirk SJ (1997): External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J of Radiat Oncol Biol Phys 39 (4): 929−935 – reference: 19 . Mano H (2020): Cancer genomic medicine in Japan. Proc Jpn Acad Ser B Phy Biol Sci 96 (7): 316−320 – reference: 8 . Válek V, Kysela P, Kala Z, Kiss I, Tomášek J & Petera J (2007): Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: A prospective randomised study. European Journal of Radiology 62 (2): 175−179 – reference: 18 . Lee KJ, Yi SW, Cha J et al (2016): A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer. Cancer Chemother Pharmacol 78 (4): 841−846 – reference: 13 . National Comprehensive Cancer Network (2021): NCCN Clinical Practice Guidelines in Oncology. Hepatobiliary Cancers (version 5). https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf (accessed February 4, 2022) – reference: 15 . Lin LL, Picus J, Drebin JA et al (2005): A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. Am J Clin Oncol 28 (3): 234−241 – reference: 20 . Nakamura H, Arai Y, Totoki Y et al (2015): Genomic spectra of biliary tract cancer. Nat Genet 47 (9): 1003−1010 – reference: 1 . National Cancer Center, Japan : Cancer Statistics. Cancer Information Service.https://ganjoho.jp/reg_stat/statistics/data/dl/index.html#a14(accessed January 10, 2022) (in Japanese) |
| SSID | ssj0058415 |
| Score | 2.2296793 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 277 |
| SubjectTerms | 化学放射線療法 放射線療法 肝門部胆管癌 胆道癌 |
| Title | 腹膜播種にて結腸閉塞を来した切除不能肝門部胆管癌の1例 |
| URI | https://www.jstage.jst.go.jp/article/juoeh/44/3/44_277/_article/-char/ja |
| Volume | 44 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of UOEH, 2022/09/01, Vol.44(3), pp.277-286 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFA-1XryIouI3PTgnScnHJJk5JrtZiqJFaKG3kGyySA-tSHvx5La0KipID5WCVQoqBbE3oR70P_Cv2La7-1_4ezPJdisKtRCGYebN7715b5J5M5kPw7jFm7ZotVqemblcmnT6iCk82TJd4eeOL-Awqz_49-77E9P8zow3M3Lq19CqpcWFbLz55K_7Sk5iVaTBrrRL9j8sOwBFAuKwL0JYGOGxbMxiwYTHIqkiPpM1FiN0WFhnccBCwcKYxS68RRZGVcSnrMhj0qqKCxZLJn0mgOOx0GZSl3IIigDrLPTK4jKoIg0iFkAIVHHJQs5iTmiirpBdFumIQwglC4siyIJsmkYoeSAn-CICHFGrRI1thRgzEf3DiZ6ejAf_ugg5ipTMwEE5i9qPqhIQGqom0Ej9kB40NSZCkgT1gvyKXtdBCQplHZ5NSUhQGmnpCL6CjThlwxKRO0wf2fSQohosdAf0qGSkGNVhs-GJF4zZq5Vl-lVR4teV1SCLpbTkgwmTngII8dwuBQIDIlIFiGWN1EHKRa4SAjVEvEIc6gPo6GPhqFuF0F2rNDhlgekIffh71YnpQzTLl9Ud7pHKW3K0c-Poc8f_7DdpHoT6zcX54uE45-ODQkdOIi_beaLIEs4TlwLQJlUO7RRMZjFcOY1UtWri7oPBTz24uvpCkapOeh-KmoMZ5gxfcBYjo2pVpXL0ps4ZZ8vGNRZqZueNkWLugjHZW_neW313sPa1u73TaX_ptD93v73prez211_sb73vLK0dbH7qtN922h_2nz_rb3zc233dW_7RW9rsrz_tL2_3lle7O1vdjVed9o699_PlRWO6EU_VJszyLhJz1nac1MwkPPemLOCn8NQPnCacPHzlnNznmc0LmutJc4FvnVOoIUQQWJmfF5bMOYbshe9eMkbn5ueKy8ZY6vLUwzDIk3nBrYynrayV-54bNPMsk2lwxRC6_skjfeBMcmzFXz150WvGmcNGft0YXXi8WNyAv72Q3VRW_A3MPLQv |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%85%B9%E8%86%9C%E6%92%AD%E7%A8%AE%E3%81%AB%E3%81%A6%E7%B5%90%E8%85%B8%E9%96%89%E5%A1%9E%E3%82%92%E6%9D%A5%E3%81%97%E3%81%9F%E5%88%87%E9%99%A4%E4%B8%8D%E8%83%BD%E8%82%9D%E9%96%80%E9%83%A8%E8%83%86%E7%AE%A1%E7%99%8C%E3%81%AE1%E4%BE%8B&rft.jtitle=Journal+of+UOEH&rft.au=%E9%BB%92%E7%94%B0%2C+%E5%AE%8F%E6%98%AD&rft.au=%E4%BC%8A%E8%97%A4%2C+%E4%B8%80%E9%A6%AC&rft.au=%E5%90%89%E7%94%B0%2C+%E6%98%B4%E5%B9%B3&rft.au=%E5%B1%B1%E5%8F%A3%2C+%E6%99%8B%E4%BD%9C&rft.date=2022-09-01&rft.pub=%E5%AD%A6%E6%A0%A1%E6%B3%95%E4%BA%BA+%E7%94%A3%E6%A5%AD%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6&rft.issn=0387-821X&rft.eissn=2187-2864&rft.volume=44&rft.issue=3&rft.spage=277&rft.epage=286&rft_id=info:doi/10.7888%2Fjuoeh.44.277&rft.externalDocID=article_juoeh_44_3_44_277_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0387-821X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0387-821X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0387-821X&client=summon |